Parnax Lab approves revised directors report for FY26
- Board approved revised directors report for FY26
- Secretarial audit report was also taken on record
- Meeting held on August 26, 2026
- Disclosure made under SEBI Regulation 30

*this image is generated using AI for illustrative purposes only.
Parnax Lab approved its revised directors report and secretarial audit report for FY26. The board meeting took place on August 26, 2026.
The directors considered these documents during a session that began at 3:30 pm and concluded at 4:00 pm. This disclosure follows an earlier outcome dated August 14, 2026.
Board Meeting Details
The board acted pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that other details from the previous filing remain unchanged.
Preet Kukreja, Company Secretary and Compliance Officer, signed the disclosure.
Historical Stock Returns for Parnax Lab
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.40% | +9.39% | 0.0% | 0.0% | 0.0% | 0.0% |
What specific revisions were made to the directors' report compared to the initial filing on August 14, 2026, and do they signal any changes in strategic direction?
How might the approval of the secretarial audit report impact Parnax Lab's compliance standing with SEBI in the upcoming regulatory cycles?
Are there any pending shareholder resolutions or major corporate actions scheduled following this board meeting that could influence stock volatility?

































